Research field
Gene Therapy
Gene therapy corrects genetic diseases by delivering functional copies of genes, editing faulty sequences, or silencing harmful gene expression using nucleic acid medicines and viral vectors. Adeno-Associated virus vectors have achieved durable therapeutic benefit in hemophilia, spinal muscular atrophy, and retinal dystrophies. CRISPR base editors make precise single-nucleotide changes without double-strand breaks, dramatically expanding the range of correctable mutations. mRNA lipid nanoparticle technology, validated at scale by COVID-19 vaccines, is being applied to metabolic and cardiovascular diseases. CAR-T cell therapies have transformed outcomes in certain blood cancers. Gene therapy is transitioning from rare disease niche to a platform for broad therapeutic application.
Top institutions
University of Pennsylvania
Harvard Broad Institute
Nationwide Children's Hospital
UCL Great Ormond Street
Généthon France
Subfields
Key technologies
Adeno-Associated Virus Vectors
Lipid Nanoparticles
CRISPR Base Editors
Antisense Oligonucleotides
Lentiviral Vectors
Free to browse · subscribe to unlock the full dataset
See the full dataset.
Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.
Sign Up Free →